ENST00000505480.6:c.-285T>C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000505480.6(ABCG2):​c.-285T>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0551 in 334,338 control chromosomes in the GnomAD database, including 625 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.048 ( 229 hom., cov: 33)
Exomes 𝑓: 0.061 ( 396 hom. )

Consequence

ABCG2
ENST00000505480.6 5_prime_UTR

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0950

Publications

9 publications found
Variant links:
Genes affected
ABCG2 (HGNC:74): (ATP binding cassette subfamily G member 2 (JR blood group)) The membrane-associated protein encoded by this gene is included in the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the White subfamily. Alternatively referred to as a breast cancer resistance protein, this protein functions as a xenobiotic transporter which may play a major role in multi-drug resistance. It likely serves as a cellular defense mechanism in response to mitoxantrone and anthracycline exposure. Significant expression of this protein has been observed in the placenta, which may suggest a potential role for this molecule in placenta tissue. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000505480.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0616 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000505480.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ABCG2
NM_001348986.2
c.-285T>C
5_prime_UTR
Exon 1 of 16NP_001335915.1
ABCG2
NM_001348988.1
c.-670T>C
5_prime_UTR
Exon 1 of 17NP_001335917.1Q9UNQ0-1
ABCG2
NM_001348987.1
c.-476T>C
5_prime_UTR
Exon 1 of 16NP_001335916.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ABCG2
ENST00000505480.6
TSL:1
c.-285T>C
5_prime_UTR
Exon 1 of 4ENSP00000426916.2F8S0F2
ABCG2
ENST00000515655.5
TSL:1
c.-19-18828T>C
intron
N/AENSP00000426917.1Q9UNQ0-2
ABCG2
ENST00000503830.2
TSL:1
c.-20+363T>C
intron
N/AENSP00000426934.2F8S0F2

Frequencies

GnomAD3 genomes
AF:
0.0476
AC:
7240
AN:
152090
Hom.:
228
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0183
Gnomad AMI
AF:
0.0691
Gnomad AMR
AF:
0.0516
Gnomad ASJ
AF:
0.0591
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0562
Gnomad FIN
AF:
0.0693
Gnomad MID
AF:
0.0701
Gnomad NFE
AF:
0.0631
Gnomad OTH
AF:
0.0497
GnomAD4 exome
AF:
0.0615
AC:
11196
AN:
182134
Hom.:
396
Cov.:
0
AF XY:
0.0623
AC XY:
6460
AN XY:
103770
show subpopulations
African (AFR)
AF:
0.0157
AC:
21
AN:
1340
American (AMR)
AF:
0.0493
AC:
337
AN:
6840
Ashkenazi Jewish (ASJ)
AF:
0.0549
AC:
184
AN:
3352
East Asian (EAS)
AF:
0.000221
AC:
1
AN:
4520
South Asian (SAS)
AF:
0.0624
AC:
2555
AN:
40936
European-Finnish (FIN)
AF:
0.0711
AC:
621
AN:
8734
Middle Eastern (MID)
AF:
0.0570
AC:
34
AN:
596
European-Non Finnish (NFE)
AF:
0.0650
AC:
6966
AN:
107208
Other (OTH)
AF:
0.0554
AC:
477
AN:
8608
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.519
Heterozygous variant carriers
0
635
1270
1906
2541
3176
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0476
AC:
7239
AN:
152204
Hom.:
229
Cov.:
33
AF XY:
0.0486
AC XY:
3618
AN XY:
74416
show subpopulations
African (AFR)
AF:
0.0183
AC:
761
AN:
41558
American (AMR)
AF:
0.0514
AC:
786
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0591
AC:
205
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5152
South Asian (SAS)
AF:
0.0566
AC:
273
AN:
4820
European-Finnish (FIN)
AF:
0.0693
AC:
735
AN:
10608
Middle Eastern (MID)
AF:
0.0685
AC:
20
AN:
292
European-Non Finnish (NFE)
AF:
0.0631
AC:
4292
AN:
67982
Other (OTH)
AF:
0.0492
AC:
104
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
371
743
1114
1486
1857
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
92
184
276
368
460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0550
Hom.:
105
Bravo
AF:
0.0438
Asia WGS
AF:
0.0260
AC:
91
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
6.6
DANN
Benign
0.65
PhyloP100
0.095
PromoterAI
0.044
Neutral
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs2231135;
hg19: chr4-89079994;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.